Financhill
Back

Defiance Nasdaq 100 Income Target ETF Vs. Insmed, Inc. Industry Stock Comparison

Sell
6

QQQT
Defiance Nasdaq 100 Income Target ETF

Last Price:
$17.62
Seasonality Move:
-13.24%
Sell
40

INSM
Insmed, Inc.

Last Price:
$166.55
Seasonality Move:
7.61%
Sell
6
Defiance Nasdaq 100 Income Target ETF (QQQT) is a Sell

Is Defiance Nasdaq 100 Income Target ETF a Buy, Sell or Hold?

  • The current Defiance Nasdaq 100 Income Target ETF [QQQT] share price is $17.59. The Score for QQQT is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • QQQT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Insmed, Inc. (INSM) is a Sell

Is Insmed, Inc. a Buy, Sell or Hold?

  • The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QQQT Stock Price Chart

What is Defiance Nasdaq 100 Income Target ETF's stock price today?

  • The Defiance Nasdaq 100 Income Target ETF share price today is $17.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QQQT is experiencing slight selling pressure.

INSM Stock Price Chart

What is Insmed, Inc.'s stock price today?

  • The Insmed, Inc. share price today is $166.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.

QQQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.47 Buy
Relative Strength Index (14 RSI): 40.46 Sell
Chaikin Money Flow: -625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.61 - 18.13) Sell
Bollinger Bands (100): (17.82 - 18.5) Sell

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 29.93 Sell
Chaikin Money Flow: -270452 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (190.54 - 208.08) Sell
Bollinger Bands (100): (130.7 - 191.18) Buy

QQQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.78 Sell
20-day SMA: 17.88 Sell
50-day SMA: 18.16 Sell
200-day SMA: 17.63 Sell
8-day EMA: 6.91 Buy
20-day EMA: 3.17 Buy
50-day EMA: 1.34 Buy
200-day EMA: 0.35 Buy

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.36 Sell
20-day SMA: 199.79 Sell
50-day SMA: 186.64 Sell
200-day SMA: 121.17 Buy
8-day EMA: 191.25 Sell
20-day EMA: 194.86 Sell
50-day EMA: 184.92 Sell
200-day EMA: 135.61 Buy

Defiance Nasdaq 100 Income Target ETF Earnings Growth & QQQT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Insmed, Inc. Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $2.60 per share.

Defiance Nasdaq 100 Income Target ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Insmed, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):